Paradigm Peptides Alternative — Pure US Peptide
Paradigm Peptides closed after its owners pleaded guilty to federal charges on December 10, 2025. The site now displays a closure notice and the owners are criminally enjoined from returning to this product category. Pure U.S. Peptides is a research-only U.S.-based vendor built for the same audience: HPLC-verified compounds, public per-batch COAs, U.S. fulfillment, and a 32-compound catalog focused on the workhorse research molecules.
What happened to Paradigm Peptides
On December 10, 2025, Paradigm Peptides owners Matthew Kawa and Jennifer Stechkober pleaded guilty to federal charges in the U.S. District Court for the Northern District of Indiana. The case was prosecuted by the U.S. Attorney's Office for the Northern District of Indiana. Matthew Kawa was sentenced on March 24, 2026. The Paradigm Peptides website now displays a closure notice, and the owners are criminally enjoined from returning to this product category.
For the official source of these facts, see the U.S. Department of Justice press release (Northern District of Indiana). Pure U.S. Peptides cites the DOJ release directly and does not speculate about additional charges, parties, or facts beyond what the Department of Justice has published.
For an audience of independent researchers, the practical effect of the closure is straightforward: a familiar name in the U.S. research-supply market is no longer available, and the original operators cannot lawfully resume operations. That leaves an estimated 30,000 to 50,000 monthly brand-search researchers looking for a replacement — and looking for a vendor with cleaner positioning than the one they just lost.
Top compounds Paradigm Peptides carried
Across multiple cached snapshots and historical product listings, Paradigm Peptides was best known to the research community for a compact set of workhorse research molecules. Pure U.S. Peptides carries each of these as a research-only product with HPLC-verified purity and a public per-batch certificate of analysis on every product page:
- • BPC-157 10mg — connective-tissue research workhorse
- • TB-500 10mg — actin-binding research peptide
- • Ipamorelin 10mg — selective ghrelin-receptor research compound
- • Selank 10mg — synthetic tuftsin-analog research peptide
- • Semax 30mg — ACTH(4-10)-fragment research peptide
- • Browse the full 32-compound catalog
Pure U.S. Peptides operates strictly within research-only positioning, maintains a tightly scoped 32-compound research catalog, and does not market human-use products.
Why a U.S.-fulfilled vendor matters now
The closure of Paradigm Peptides arrives during a period of rapidly tightening federal oversight of the broader research-supply market. For an audience of independent researchers choosing a new vendor, three structural questions matter more than they did even twelve months ago:
- Where is fulfillment based? Domestic warehouses ship faster, are not subject to import-seizure risk, and let researchers verify chain-of-custody on every order. Pure U.S. Peptides ships same-day from a U.S. fulfillment center.
- Are COAs public per batch? A vendor that requires email-request COAs is asking researchers to trust a process they cannot audit. Pure U.S. Peptides publishes the lot-specific certificate of analysis from an independent U.S. lab on each product page.
- Is the catalog tightly research-scoped? Vendors carrying products that drift outside research-only positioning attract regulatory scrutiny that cleaner vendors do not. Pure U.S. Peptides maintains a focused 32-compound catalog of the workhorse research molecules.
Pure US Peptide difference
| Criterion | Pure US Peptide | Paradigm Peptides |
|---|---|---|
| Business status | Operating | Closed (federal case) |
| HPLC purity | 99%+ verified, third-party | Site offline — not verifiable |
| COA availability | Public, per-batch, on each product page | Site offline |
| Fulfillment | Same-day from U.S. warehouse | N/A — closed |
| Catalog scope | 32 research compounds (research-only) | Mixed catalog (historical) |
| Payment methods | Card, Zelle, Venmo, Cash App | N/A — closed |
Switching guide for past Paradigm customers
- Document what you ordered. Save invoices, payment confirmations, and any tracking numbers from your last Paradigm Peptides order. These records are useful regardless of how the underlying matter resolves.
- Verify the compound, not the brand. The research compound (e.g. BPC-157, Selank) is the same molecule across compliant vendors. What changes is the vendor's purity verification process and labeling discipline.
- Read the COA before purchasing. Pure U.S. Peptides links the per-batch certificate of analysis on each product page. Open it and confirm the lot, the assay method (HPLC), and the purity number before you order.
- Apply your switch code. Use PARADIGMSWITCH25 at checkout for 20% off your first order. The code is applied automatically when you click through from this page.
- Be cautious of imitator domains. A federally closed brand is a common target for scam relaunches. There is no public DOJ filing indicating a Paradigm Peptides relaunch. Treat any "new Paradigm" site with suspicion.
Ready to rebuild your supplier shortlist?
Use code PARADIGMSWITCH25 for 20% off your first order. Applied automatically when you click below.
Browse the catalog →Frequently asked
Why is Paradigm Peptides no longer operating?
According to the U.S. Department of Justice (Northern District of Indiana), Paradigm Peptides owners Matthew Kawa and Jennifer Stechkober pleaded guilty to federal charges on December 10, 2025. The Paradigm Peptides website now displays a closure notice. The owners are criminally enjoined and cannot legally return to operating in this space.
Is Paradigm Peptides coming back under a new name?
There is no public DOJ filing or company announcement indicating a relaunch. Researchers should be cautious of any site claiming to be Paradigm Peptides under a new domain — the original owners are subject to a federal criminal disposition and cannot lawfully resume operations in this product category.
When was Matthew Kawa sentenced?
Matthew Kawa was sentenced on March 24, 2026, following the December 10, 2025 guilty plea, per the DOJ press release from the U.S. Attorney's Office for the Northern District of Indiana.
Is Pure U.S. Peptides a direct replacement for Paradigm Peptides?
Pure U.S. Peptides is a U.S.-based research-supply vendor that carries the workhorse research compounds Paradigm customers most often searched for, including BPC-157, TB-500, Ipamorelin, Selank, and Semax. Pure U.S. Peptides is operated independently and is not affiliated with Paradigm Peptides in any way.
What about my pending Paradigm Peptides order?
Pure U.S. Peptides cannot speak to Paradigm's order or refund process. The Paradigm site closure notice is the only official communication researchers have to work from. We recommend documenting any pending orders, retaining payment records, and consulting independent counsel for further options.
Does Pure U.S. Peptides carry the same compounds Paradigm did?
Pure U.S. Peptides carries 32 research compounds focused on the most-requested research molecules — including BPC-157, TB-500, Ipamorelin, Selank, and Semax. Pure U.S. Peptides operates strictly within research-only positioning and maintains a tightly scoped catalog.
Is Pure U.S. Peptides involved in the federal case against Paradigm?
No. Pure U.S. Peptides is a separate, independently operated company. We have no business relationship with Paradigm Peptides, Matthew Kawa, or Jennifer Stechkober, and no involvement in the underlying DOJ case.
What is research-use-only labeling?
Every compound sold by Pure U.S. Peptides is labeled and intended exclusively for in-vitro research and laboratory use by qualified investigators. The compounds are not intended for human or veterinary consumption, diagnostic use, or any other application.